14,734 Tenet Healthcare Corporation $THC Shares Bought by Cibc World Market Inc.

Cibc World Market Inc. increased its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 129.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 26,118 shares of the company’s stock after purchasing an additional 14,734 shares during the period. Cibc World Market Inc.’s holdings in Tenet Healthcare were worth $6,675,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Ashton Thomas Private Wealth LLC grew its holdings in Tenet Healthcare by 1.7% in the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 2,468 shares of the company’s stock valued at $631,000 after buying an additional 42 shares in the last quarter. Bessemer Group Inc. increased its stake in shares of Tenet Healthcare by 5.1% during the 3rd quarter. Bessemer Group Inc. now owns 892 shares of the company’s stock worth $227,000 after purchasing an additional 43 shares during the last quarter. Parallel Advisors LLC grew its stake in Tenet Healthcare by 4.4% during the third quarter. Parallel Advisors LLC now owns 1,282 shares of the company’s stock valued at $328,000 after acquiring an additional 54 shares in the last quarter. MGO One Seven LLC grew its position in Tenet Healthcare by 2.5% during the third quarter. MGO One Seven LLC now owns 2,566 shares of the company’s stock valued at $656,000 after acquiring an additional 63 shares during the last quarter. Finally, Mather Group LLC. raised its position in Tenet Healthcare by 126.9% during the 3rd quarter. Mather Group LLC. now owns 118 shares of the company’s stock valued at $30,000 after purchasing an additional 66 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Tenet Healthcare

In related news, Director Cecil Haney sold 1,300 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $278.03, for a total value of $361,439.00. Following the completion of the transaction, the director owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. This trade represents a 9.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Lisa Foo sold 24,000 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $266.32, for a total value of $6,391,680.00. Following the transaction, the executive vice president directly owned 8,053 shares in the company, valued at approximately $2,144,674.96. This represents a 74.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 99,462 shares of company stock valued at $27,081,234 in the last 90 days. 0.97% of the stock is owned by corporate insiders.

Trending Headlines about Tenet Healthcare

Investors following THC have been watching these headlines:

  • Positive Sentiment: Zacks Research raised its EPS forecasts across several quarters and full years. Its FY2027 estimate increased to $19.77 from $18.91, and its FY2028 estimate rose to $20.98 from $20.09. Higher analyst expectations may support investor sentiment by suggesting improved earnings prospects. Tenet Healthcare analyst estimates
  • Positive Sentiment: A separate Zacks article characterized THC as a top-ranked momentum stock, a potentially favorable signal for investors focused on price trends. Zacks momentum-stock article
  • Neutral Sentiment: Despite the estimate increases, Zacks Research maintained a “Hold” rating, indicating it did not make a more bullish recommendation. Tenet Healthcare analyst information

Tenet Healthcare Stock Down 0.1%

NYSE THC opened at $263.34 on Friday. The business has a 50 day moving average price of $268.86 and a two-hundred day moving average price of $226.99. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $301.44. The stock has a market cap of $20.96 billion, a PE ratio of 7.64, a P/E/G ratio of 1.41 and a beta of 1.20. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its earnings results on Thursday, October 29th. The company reported $6.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.68 by $1.96. The business had revenue of $6.28 billion for the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The company’s revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.70 EPS. As a group, sell-side analysts predict that Tenet Healthcare Corporation will post 22.29 EPS for the current fiscal year.

Analyst Ratings Changes

THC has been the topic of several recent analyst reports. Stephens reissued an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. BMO Capital Markets began coverage on shares of Tenet Healthcare in a research report on Tuesday, September 22nd. They set a “market perform” rating and a $265.00 price target on the stock. Truist Financial reissued a “buy” rating and issued a $305.00 target price (up from $290.00) on shares of Tenet Healthcare in a research note on Tuesday, November 3rd. Piper Sandler set a $308.00 target price on Tenet Healthcare in a research report on Monday, July 27th. Finally, Royal Bank Of Canada raised their target price on Tenet Healthcare from $283.00 to $304.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $296.65.

Check Out Our Latest Report on Tenet Healthcare

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.

Featured Stories

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.